Ally Bridge Group, a Hong Kong-based healthcare-focused private equity firm, has proposed a HK$2.34 billion (US$301 million) privatization deal to …
CITIC M&A Fund, Legend Capital Lead $280M Investment In Pharmaron
CITIC M&A Fund and Legend Capital have agreed to lead an investor consortium to invest US$280 million in Pharmaron, a …
Hillhouse, CITIC PE-Backed BeiGene Files For US IPO
Beijing-based oncology research and development firm BeiGene (Beijing) Co., Ltd., backed by Hillhouse Capital and CITIC Private Equity, has filed …
ZY Investments To Jointly Launch $473M China Healthcare M&A Fund
Chinese healthcare-focused private equity fund ZY Investments has signed an agreement with Shenzhen-listed Sundiro Holding Co., Ltd and the company's …
C-Bridge Capital Leads $35M New Round In Ascletis
Chinese pharmaceutical start-up Ascletis has completed RMB220 million (US$35 million) new round of financing led by C-Bridge Capital, according to …
Shanghai Pharma Seeks $469M For Healthcare Venture Fund
Chinese drug maker Shanghai Pharmaceuticals Holding Co., Ltd. plans to launch a venture capital investment fund to back promising healthcare …
CITIC PE-Backed 3SBio Acquires Wansheng Pharma
Shenyang, Liaoning province-based Chinese bio-pharmaceutical firm 3SBio Inc., backed by CITIC Private Equity Funds Management Co. (CITIC PE), has acquired …
WuXi PharmaTech Unit To Raise $80M In New Funding
Chinese contract research and development services provider for the pharmaceutical industry WuXi PharmaTech (Cayman) Inc. says its small-molecule drugs manufacturing …
CITIC PE-Backed 3SBio Seeks $712M Hong Kong IPO
Shenyang, Liaoning province-based Chinese bio-pharmaceutical firm 3SBio Inc., backed by CITIC Private Equity Funds Management Co. (CITIC PE), is seeking …
Fosun, Hopu Among Investors Acquiring Biotech Firm Ambrx
A Chinese investor consortium has agreed to acquire San Diego, California-based biotechnology firm Ambrx Inc., according to a company announcement. …
Hony Capital Offloads CSPC Pharma Shares For $1.26B
Beijing-based Chinese private equity firm Hony Capital has offloaded 1.37 billion shares of Chinese generic drugs maker CSPC Pharmaceutical Group …
Qiming, TF Capital Lead $10M Series A In CANbridge Life Sciences
Beijing-based bio-pharmaceutical company CANbridge Life Sciences Ltd. has completed US$10 million series A financing from Qiming Venture Partners and TF …
BVCF Leads Series A Round For Shanghai Drug Maker CARsgen
Shanghai-based immunotherapy firm CARsgen says it has completed an undisclosed amount of series A financing led by Shanghai-based BVCF, a …
Blackstone To Acquire Stake In Xinrong Best Medical Instrument
U.S. private equity giant Blackstone Group L.P. has agreed to acquire a stake in SuZhou city-based Chinese orthopedic medical instruments …
Baird Capital Exits Frontage Laboratories Through Trade Sale
U.S. private equity firm Baird Capital has sold its interests in its portfolio company Frontage Laboratories, Inc. to Hangzhou Tigermed …
Cathay Capital Invest $24.5M In Kunming Shenghuo Pharma
Sino-French private equity firm Cathay Capital Private Equity says it has invested RMB150 million (US$24.5 million) in traditional Chinese medicine …